Previous in vivo studies demonstrated that clearance of encapsulated Haemophilus influenzae from blood is associated with the deposition of C3 on these bacteria and is independent of the later complement components (C5-C9). Since clearance of encapsulated bacteria is determined by phagocytosis of bacteria by fixed tissue macrophages, we studied the interaction of H. influenzae type b with macrophages in vitro. Organisms bound to macrophages in the presence of nonimmune serum. Binding was not evident in heat-treated serum or in serum from complement depleted animals and was inhibited by F(ab')2 fragments of antibody to C3 and by blockade of the macrophage complement receptor type 3. The majority of organisms bound in the presence of complement alone remained extracellular.
Introduction
Phagocytosis is an important host defense mechanism against encapsulated Haemophilus influenzae type b (1) (2) (3) (4) (5) (6) . Ingestion of these organisms at local sites of infection by polymorphonuclear leukocytes (PMNs) may be important in preventing spread of infection, whereas phagocytosis by fixed macrophages effects the clearance of bacteria from blood (7) . This macrophage-dependent clearance is critical in protecting the host from disseminated infection (8) . Virulent H. influenzae type b, which can cause sustained, high-magnitude bacteremia, does so by evading or overwhelming antibody-independent mechanisms of host defense (9) (10) (11) (12) . The mechanisms by which this organism evades host defenses, however, are poorly understood. A recent in vivo study from our laboratory suggested that complement plays a major role as an opsonin in determining the antibody-independent clearance of H. influenzae from blood (6) . Clearance was impaired relative to that seen in C3-depleted animals, but was not dependent upon the terminal components of complement. These results are consistent with observations of others that suggest complement is critical for the normal clearance ofthese bacteria from blood (13) and with the observations that patients with deficiencies in the early components of complement (Cl -C3) are at increased risk for H. influenzae infection while those deficient in the late components (C5-C9) are not (14, 15) . Together these observations suggest that complement plays an important role as an opsonin in the host defense against H. influenzae type b, similar to its role with other bacteria including Streptococcus pneumoniae (16) , Escherichia coli (17) , and Legionella pneumophila (18) .
The study presented here was conducted in order to better characterize mechanisms of host defense in an in vitro model system. We studied the opsonic effect of serum from nonimmune animals in which blood clearance of H. influenzae type b had been previously defined (6) and assessed the role of complement in effecting phagocytosis using the phagocyte responsible for blood clearance, the macrophage.
Methods
Sera. Nonimmune serum (NI-S)' and serum from cobra venom factor treated mice (CoVF-S) was collected from male BlO.D2/oSn mice (Jackson Laboratories, Bar Harbor, ME) and stored at -70'C as described (6) . Clearance of H. influenzae type b from blood has been defined in our laboratory in nonimmune and CoVF treated mice. In this study (6) , 54% (7/13) of nonimmune animals were no longer bacteremic and four of the six (66%) bacteremic animals had > 100-fold reduction in quantitative bacteremia by 24 h after intravenous inoculation of H. influenzae type b. In contrast, only 17% (2/12) of these C3-depleted animals were no longer bacteremic and none of the bacteremic animals had reduced their quantitative bacteremia 100- fold by 24 h.
Serum complement activity was inactivated by heating serum at 560C for 45 min. Convalescent serum (Con-S) was collected from mice 4 wk after the last of two biweekly inoculations ofH. influenzae type b (Eagan isolate) and was stored at -70'C. C3 levels in serum were assessed by radial immunodiffusion (RID) (6) and by a serum C3 fixation immunofluorescent assay (IFA) (6) . C3 levels in NI-S and Con-S ranged from 290 to 359 mg/dl by RID. C3 . Monolayers were fixed in 3.3% neutral buffered formalin (A, B, G, H), 100% methanol (C, D, J, I), or 3% paraformaldehyde (E and F), and then incubated in either rabbit antibody to sheep erythrocytes (A-F) or rabbit antiserum to H. influenzae type b (G-J). Monolayers were then incubated with FITC-conjugated goat antibody to rabbit immunoglobulin. Fields are shown as viewed with phase contrast microscopy (A, C, E, G, I), or with fluorescent microscopy (B, D, F, H, J). Ingested erythrocytes were visualized with fluorescent microscopy in methanol-fixed monolayers (D) as intensely fluorescent stained cells. This staining of ingested erythrocytes was not seen after formalin (B) or paraformaldehyde (F) fixation. Similarly, staining of H. influenzae after formalin fixation (H) was much less than that seen after methanol fixation (J), suggesting the majority of bacteria were intracellular rather than peripherally bound following incubation in the presence of type specific monoclonal mouse IgGl antibody. Arrows indicate examples of stained bacteria and corresponding location on monolayers seen by phase contrast microscopy (methanol fixed, I and J) and of apparent intracellular organisms as seen by phase microscopy and corresponding location of unstained bacteria (formalin fixed, G and H). fixation titers by IFA ranged from 1: 16 to 1:32. CoVF-S had C3 levels of less than 20 mg/dl by RID. C3 fixation was not detected by IFA in CoVF-S or in heat-inactivated serum.
Serum IgG and IgM antibody was measured by an ELISA to whole organisms (6) . Pooled NI-S had a titer < 1:10, the lower limits of detection of antibody with this assay. Con-S had a titer of 1:2,560. Monoclonal antibody to type b capsule (E 1 7-5) assayed at a concentration of 100 Asg/ml had an ELISA titer of 1:320.
Organisms. Four isolates of H. influenzae type b, were suspended in skim milk broth (Difco Laboratories, Detroit, MI) and stored at -700C. Isolate Eag (Eagan strain) has been previously studied (2, 3, 6) and was derived from a clinical blood isolate. Isolate R-56 (strain KW20b), a type b transformant of a capsule-deficient isolate (19) Complement deposition on bacteria. C3 fixation to bacteria in the presence of Con-S and NI-S was assessed by an IFA using an antibody to mouse C3 as previously described (6 (21) .
Methods for assessing interaction of bacteria with macrophages. Association of organisms with macrophages was assessed by a radiobinding assay and by direct. visualization using immunofluorescent microscopy of methanol fixed monolayers. Each assay measured both peripherally bound and internalized bacteria. Data from these assays are therefore expressed as "macrophage-associated organisms." The radiobinding assay was performed by addition of 1 to 5 X 10 (7) tritium-labeled organisms to monolayers of 0.8 to 3.0 X 10 (5) (Fig. 1) . The number of organisms associated with macrophages was determined by counting the number of bacteria associated with 100 macrophages.
Ingestion of organisms was distinguished from binding by comparing the number of immunofluorescent-stained organisms associated with methanol-fixed macrophages to the number seen associated with formalin-fixed macrophages. Similar to previous observations (22) , 100% methanol fixation permitted immunofluorescent staining of all cell-associated particles while formalin or paraformaldehyde fixation permitted staining of only those particles peripherally bound. As a control, the exclusion of fluorescent antibody staining of internalized particles in formalin-fixed monolayers was demonstrated with ingested sheep red blood cells (SRBCs). SRBCs preincubated for 30 min at 370C in a 1:5,000 dilution of rabbit antibody to SRBC (Cordis Laboratories, Miami, FL) were incubated with monolayers for 1 h. Monolayers were then washed to remove unbound SRBCs and incubated an additional hour to allow internalization of bound SRBCs. Monolayers were then washed and fixed in either 3.3% formalin (formalin solution, neutral buffered; Sigma Chemical Co., St. Louis, MO, final preparation contained less than 5% methanol), 100% methanol, or 3% paraformaldehyde. Fixed monolayers were then incubated for two 20-min periods in a 1: 100 dilution of rabbit antibody to SRBCs (Cordis Laboratories) and a 1:100 dilution of FITC-conjugated goat antibody to rabbit immunoglobulin. Ingested SRBCs were identified by a rim of intense fluorescence in methanol-fixed monolayers but were not evident in formalin-or paraformaldehyde-fixed macrophages (Fig. 2 , A-F). These same fixation and similar immunofluorescent staining techniques were used to assess ingestion versus binding of H. influenzae (Fig. 2 , G-J). The number of organisms ingested was calculated by subtracting the number of bound bacteria (formalin fixed) from the number of macrophage associated organisms (methanol fixed). For each experiment an ingestion index was calculated as: 1 -(number of organisms bound/total organisms associated).
In sequential incubation assays monolayers adherent to glass coverslips were incubated with organisms and 8% serum (NI-S) for 1 h at 37°C, washed to remove unbound organisms, and reincubated with either buffer containing antibody, 8% heat inactivated Con-S, 8% heat inactivated NI-S, or 8% fresh NI-S for 30 min. Monolayers were then prepared and fixed as above.
Antibodies and macrophage receptor blockade. Monoclonal antibody M 1/70, a rat IgG2b antibody to the alpha chain of MAC 1, the mouse macrophage complement receptor CR3, was prepared as described (21) . Inhibition of CR3-dependent binding was achieved by adding 8 Mg of monoclonal antibody after the final PB wash of monolayers 20 min before adding particles as described (21) . Similar results obtained with purified antibody were achieved using 3% culture supernatant. These concentrations of antibody were chosen to give maximal inhibition of H. influenzae binding in the presence of 8% fresh mouse serum but less than 10% inhibition of IgG-coated SRBC binding in the absence of serum.
Inhibition of binding to the lectin-like site ofthe CR3 was achieved using N-acetyl-D-glucosamine (NADG; Sigma) (23 (27) , were provided by Dr. T. Kinoshita (Osaka, Japan). Polyclonal rabbit serum to the protein encoded for by mCRY used at 35 tg/ml protein and purified monoclonal antibodies used at a concentrations of ,g/ml did not inhibit the binding of C3-coated SRBCs or C3-coated H. influenzae type b to resident macrophages. Monolayers incubated with these reagents at these concentrations failed to show fluorescence while monolayers incubated with M1/70 (2.6 Ag/ml) demonstrated macrophage membrane fluorescence. These observations suggest that receptor for C3b expression in unstimulated mouse phagocytes may be considerably less than expression of CR3 in these cells (27) .
Effect of reagents on binding and ingestion of organisms was calculated for each experiment as an inhibition index: 1 -(number of organisms associated in presence of reagent/number of organisms associated without reagent).
Statistical analysis. Differences were compared using Student's t test (28) . Differences between indices (nonparametric data) were compared using Wilcoxon's rank sum test (28) . Estimates of variance were calculated as the standard deviation (28).
Results
Complement deposition on H. influenzae. C3 deposition on all four isolates of H. influenzae type b after a 30-min incubation in nonimmune and convalescent mouse serum was demonstrated by immunofluorescent staining of organisms with FITC-conjugated anti-mouse C3 (6). C3 deposition was not evident after incubation without serum, with serum from cobra venom factor-treated animals, with serum heated to 56°C for 45 min or with purified monoclonal antibody E 1 17-5 in the absence of fresh mouse serum.
C3bi deposition on H. influenzae type b after incubation with human serum was also assessed by immunofluorescence using clone 9 monoclonal antibody to human C3bi. C3bi was deposited on all four isolates of H. influenzae after a 30-min incubation in either C8 deficient or agammaglobulinemic human serum. Effect of nonimmune serum on H. influenzae type b interaction with macrophages. Radiobinding assays and direct visualization of fluorescent stained monolayers were used to measure the number of organisms associated with macrophages. The average number of organisms associated with macrophages in the absence of serum as determined by the radiobinding assay was 0.2±0.3 organisms/macrophage. Direct visualization of these monolayers consistently showed < 0.1 organisms/macrophage even in experiments where the inoculum exceeded 800 organisms/macrophage.
Nonimmune serum enhanced the interaction of all four isolates of H. influenzae type b studied with macrophage monolayers (Table I ). The number of organisms associated with monolayers as determined by the radiobinding assay ranged from 3 to 18 organisms per macrophage corresponding to between 800 and 3,500 cpm/well above background and increased with the size of the inoculum (Fig. 3) . These radiobinding results were confirmed by direct visualization of methanol-fixed, fluorescent-stained monolayers. The number of organisms observed to be associated with macrophages was similar to the number calculated using the radiobinding assay.
Association of organisms with macrophage monolayers was not evident when heat-inactivated serum or serum from CoVF-treated mice was used ( Table I ). The number of organisms associated with monolayers in the presence of these sera was not significantly different from the number associated with monolayers in the absence of serum. Lack of association of organisms with macrophages in the presence of these sera was confirmed by the radiobinding assay.
As another measure of the specificity of this interaction the interaction of organisms with fibroblasts was studied. Using radiolabeled organisms the calculated number of organisms associated with fibroblasts was < 0.5 organisms/macrophage corresponding to < 100 cpm/well. Under these conditions the number of organisms associated with macrophages as determined by direct visualization was reduced from the control value of 10.7 organisms/macrophage to 0.2 organism/macrophage (inhibition index 0.99±0.01), the level seen when macrophages were incubated with organisms in the absence of serum (Table II) . Antibody fragments to C3 had little inhibitory effect when the organisms were incubated with monoclonal antibody to H. influenzae type b (Table II) . Interestingly, this anti-C3 reagent also reduced bacterial association to levels approximating background when monolayers were incubated in the presence of convalescent serum (Table II) (Table II) . This observation is similar to those made using anti-human CR3 monoclonal antibodies, human neutrophils and IgG coated particles (24) .
rect of F(ab')2 anti-C3 fragments on serum-dependent Inhibition of the association of particles via the lectin-like ig and ingestion. F(ab')2 fragments to murine C3 were site of CR3 was assessed using NADG. 100 mM NADG re-.o specifically inhibit C3-dependent opsonization and duced zymosan binding from 1.3±0.4 to 0.7±0.1 particles/ ig to macrophages. This reagent used at a concentration macrophage (n = 3) similar to that described with neutrophils 1tg/ml inhibited 85% of rabbit red blood cell binding to (24) . However, NADG had no effect on H. influenzae type b ophages in the presence of C5 deficient serum but < 10% binding to macrophages in the presence of 8% nonimmune coated sheep red blood cell binding. F(ab')2 fragments serum (10.7±2.1 vs. 11.5±1.7 organisms/macrophage, n = 4, tg/ml) were added to monolayers before and during in-mean inoculum±SD = 455±114 CFU/macrophage). (Table  III) . In contrast, incubation with convalescent serum, although not increasing the total number of organisms associated with macrophages, did increase the fraction of organisms ingested.
As shown in Table III the percentage of organisms ingested rose from 11% to 55%. Most ingested organisms appeared to be within cytoplasmic vacuoles as seen with phase contrast microscopy. These ingested organisms were not visible when examined by fluorescent microscopy after formalin fixation but were clearly fluorescent in methanol fixed monolayers (Fig. 2, G-J) .
Similar results were obtained with bacteria incubated in the presence of monoclonal antibody (El to H. influenzae type b. Incubation of monolayers with H. influenzae in the presence of 6.7 ug/ml ofEl 17-5 resulted in a number oforganisms associated with macrophages that was comparable to that achieved in 8% nonimmune serum. However, 87% of these organisms were ingested compared to the 1 1% that were ingested in the presence of nonimmune serum (Table II) . 16 .0±1.5 organisms/macrophage (n = 2) and 11.8±3.3 organisms/macrophage (n = 4), respectively, and the mean ingestion index for both of these sequential incubations was < 0.17. (Table II) but had little or no effect on organism association with macrophages in the presence of nonimmune serum (Fig. 4) . This reagent did not significantly affect the total number of organisms associated with monolayers in the presence of convalescent serum (Table II) . Incubation with 2.4G2, however, did reduce the mean ingestion index under these conditions from 0.47 to 0.20 (P < 0.05 by rank sum) (12.3±4.0 total associated/6.4±3.4 total bound versus 11.0±2.7 total associated/9.6±5.5 total bound, n = 4, inoculum size 543±62).
Effect ofserum on binding versus ingestion ofH. influenzae by macrophages. Differentiation of binding from ingestion of organisms by macrophages was accomplished by direct visualDiscussion Several previous in vivo studies have demonstrated that complement is involved in host defense against H. influenzae (6, 13, 15) . The results of the present study suggest a mechanism by which complement plays this role. In examining the interaction of H. influenzae with mouse peritoneal macrophages in vitro we found that these organisms do not bind to macrophages in the absence of serum. However, serum taken from animals which we have previously shown (6) to be capable of promptly clearing organisms from their blood stream, was able to efficiently promote the interaction of these organisms with macrophages. Further, the same procedures which impaired the clearance process in the animal also impaired the ability of serum from these animals to mediate this in vitro attachment. Both the in vivo process previously studied, and the in vitro phenomena reported in this paper, require the participation of * Mean number of organisms/macrophage ± SD as determined by immunofluorescent microscopy following methanol fixation (total associated) and formalin fixation (bound). t C3 deposition on H. influenzae type b as determined by immunofluorescent assay using FHTC-conjugated goat anti-mouse C3. Experiments performed with IgGI were done in the absence of fresh serum. § Ingestion index ± standard deviation. Index was calculated for each experiment as: I -(organisms bound/total organisms associated). Ingestion indices for experiments performed in 8% Con-S and IgG I were significantly different as determined by rank sum, P < 0.05, compared to NI-S. "lAntibody titer of IgG and IgM determined by ELISA using whole organisms. ' Difference not significant, P > 0.1, when compared to organisms bound and ingested in NI-S. ** Difference significant, P < 0.01, when compared to organisms bound in NI-S.
the early complement components and depend upon the fixation of C3 to the bacterial surface. This deposition of C3 can occur in nonimmune serum via activation of the alternative complement pathway (6, 29, 30) and is independent of bacteriolysis. This correlation of in vivo clearance with in vitro enhancement of binding suggests that the role of complement in enhancing clearance of H. influenzae type b from blood is due to its ability to enhance the interaction of these bacteria with macrophages. Previous in vitro work using PMNs suggested that complement was not sufficient to mediate phagocytosis of H. influenzae type b (1 1). In the study presented here, however, we demonstrated that incubation with nonimmune serum significantly increased the number of organisms associated with macrophage monolayers above that seen in the absence of serum (Table I) . Binding was readily demonstrable in nonimmune serum that had no detectable antibody to H. influenzae type b as determined by a whole organism ELISA. Binding also occurred despite the presence of an antibody to the Fc receptor in sufficient quantity to block IgG-coated SRBC binding. This indicated that these pathogens do interact with macrophages via serum-dependent, but antibody-independent mechanisms. Complement's role in determining this interaction was initially suggested by the reduction of binding to background levels in the presence of heat-inactivated serum or in serum from cobra venom factor-treated animals.
The specific role of C3 in mediating association of organisms with macrophages in serum was demonstrated by inhibition of this interaction with F(ab')2 anti-mouse C3 fragments. These fragments decreased the binding seen in the presence of nonimmune and of convalescent serum to levels seen in the absence of serum. This inhibition was specific, as these fragments did not inhibit IgG-coated sheep red blood cell binding or IgG 1-mediated phagocytosis of H. influenzae (Table II) .
This association was further characterized as occurring largely via the macrophage complement receptor type 3 (CR3). Reagents that recognize mouse leukocyte surface proteins that bind C3b-coated particles had no effect on the binding of organisms to monolayers. However, CR3 blockade using monoclonal antibody to this receptor (M1/70) inhibited over 75% of the interaction of all four isolates examined, when assayed in the presence of nonimmune serum (Fig. 4) . This inhibition was specific to the alpha chain of the mouse CR3, as the interaction was not affected by monoclonal antibody directed against the beta chain of CR3. Further, NADG, used in concentrations sufficient to inhibit the binding of zymosan to macrophages, did not inhibit the binding of H. influenzae. These observations support the hypothesis that the complement-dependent binding seen in this in vitro system occurs largely via the macrophage CR3, and furthermore that it occurs via the alpha chain of CR3 and is independent of the lectin-like site on this receptor.
To determine whether the interaction ofbacteria and macrophages reflected ingestion of the organisms, or merely their binding to the macrophage surface, we carried out immunofluorescent microscopy on monolayers fixed with either methanol or formalin. In nonimmune serum the majority of organisms (89%) associated with monolayers were bound and not ingested. These findings are consistent with previous observations that in resident macrophages, complement receptors are more efficient in mediating binding than ingestion of C3 coated particles (24, 31, 32) .
Using these same immunofluorescent staining methods, binding and ingestion of organisms was assessed in the presence of antibody. Convalescent, high antibody titer serum increased the percentage of organisms ingested from 11% to 55%. The number of organisms ingested in the presence ofthis serum was comparable to that seen when the assays were performed in the presence of a purified IgGl monoclonal against type b capsule (El . The increased ingestion in the presence of convalescent serum or with IgG 1 monoclonal El 17-5 alone, suggests that while C3 mediates the early recognition leading to bacterial binding, antibody is more effective in mediating internalization of these encapsulated bacteria. This is also suggested by the reduction in ingestion mediated by convalescent serum after incubation with monoclonal antibody to the Fc receptor and the sequential incubation experiments in which -50% of organisms originally bound with nonimmune serum were then ingested after subsequent incubation with either monoclonal antibody El 17-5 or heat-inactivated convalescent serum. This effect was shown using reduced concentrations of purified monoclonal antibody that were incapable ofpromoting phagocytosis oforganisms in the absence offresh serum. This result is similar to that previously described with sheep red blood cells (33) This function may be critical in determining the ingestion of organisms by macrophages in the presence of low concentrations of opsonic antibody.
Our earlier in vivo studies (6) demonstrated that C3 opsonization is associated with the early blood clearance of H. influenzae type b. The results of the in vitro studies presented here suggest that complement directs this early clearance of organisms from blood by enhancing the interaction of organisms with macrophages. This interaction occurs in the absence of antibody and would be expected to increase reticuloendothelial sequestration of organisms similar to that previously described with other encapsulated bacteria in the nonimmune host (34) . The reversibility or permanence of this sequestration, and the effect ofthis process on bacterial viability remain open questions. The importance of complement mediated binding to macrophages, however, should not only be considered as an antibody-independent mechanism of defense but also one that may be critical for determining antibody-mediated clearance in the immune host as well. This is suggested by our observation that complement was required for ingestion ofbacteria in the presence ofeither convalescent serum or concentrations of monoclonal antibody that were incapable of promoting phagocytosis on their own.
This study demonstrates the importance ofcomplement in mediating phagocytosis of H. influenzae type b by the macrophage and indicates that a better understanding of the immunology of H. influenzae type b infection awaits further definition of the interaction of these organisms with macrophages.
